Highlights from Day 2 of the ESC 2021 congress – MASTER DAPT

Presented by Dr. Marco Valgimigli, the MASTER DAPT trial assessed whether 1 month of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), with a…

View More Highlights from Day 2 of the ESC 2021 congress – MASTER DAPT
ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement

STEMI after TAVR associated with poorer outcomes.

By Ahmed El-Medany Longer door-to-balloon times and higher percutaneous coronary intervention (PCI) failure rate were observed in a multicentre study by Faroux et al. 118…

View More STEMI after TAVR associated with poorer outcomes.
Image of a heart with myocardial infarction

Prasugrel and ticagrelor associated with similar efficacy and safety following myocardial infarction

By Ahmed El-Medany In a large retrospective study by Venetsanos et al, researchers analysed 37,990 patients from the SWEDEHEART registry with myocardial infarction (MI) who…

View More Prasugrel and ticagrelor associated with similar efficacy and safety following myocardial infarction